2023 Form 5500 filing — Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241008101829NAL0017394433001) for Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan, reported by Teva Pharmaceuticals Usa, Inc. under EIN 22-1734359 and plan number 510. It reports 5,181 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$791Reported net assets
Participants5.2K5,181
Provider compensation$5K1 Schedule C row(s)$5,000
Schedules filedSchedule H, Schedule CLoaded schedules
- EFAST2 acknowledgement
- 20241008101829NAL0017394433001
- Plan sponsor
- Teva Pharmaceuticals Usa, Inc.
- EIN
- 22-1734359
- Plan number
- 510
- Location
- Parsippany, NJ
- Received date
- not reported in the loaded dataset
Schedule H · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$791 total assets
Net assets$791Liabilities$0
Full reported line items
- Total assets (EOY)
- $791
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $791
- Employer contributions
- $4,572,772
- Total income / additions
- $4,574,012
- Benefits paid
- $4,574,272
- Administrative expenses
- $5,000
- Total expenses
- $4,579,272
- Net increase / (decrease)
- -$5,260
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Bank Of America, Na | NONE | $5,000 | not reported in the loaded dataset |